Pila Pharma (Sweden) Performance
| PILA Stock | 2.03 0.03 1.46% |
The company holds a Beta of 0.74, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pila Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pila Pharma is expected to be smaller as well. At this point, Pila Pharma AB has a negative expected return of -0.19%. Please make sure to check Pila Pharma's total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to decide if Pila Pharma AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pila Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Pila |
Pila Pharma Relative Risk vs. Return Landscape
If you would invest 234.00 in Pila Pharma AB on October 4, 2025 and sell it today you would lose (31.00) from holding Pila Pharma AB or give up 13.25% of portfolio value over 90 days. Pila Pharma AB is generating negative expected returns and assumes 2.9526% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Pila, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pila Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pila Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pila Pharma AB, and traders can use it to determine the average amount a Pila Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0645
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PILA |
Estimated Market Risk
| 2.95 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pila Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pila Pharma by adding Pila Pharma to a well-diversified portfolio.
Pila Pharma Fundamentals Growth
Pila Stock prices reflect investors' perceptions of the future prospects and financial health of Pila Pharma, and Pila Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pila Stock performance.
| Return On Equity | -1.3 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (4.58) % | |||
| Current Valuation | 48.17 M | |||
| Shares Outstanding | 18.41 M | |||
| Price To Book | 7.07 X | |||
| Price To Sales | 25.21 X | |||
| Revenue | 719.23 K | |||
| EBITDA | (17.16 M) | |||
| Book Value Per Share | 0.47 X | |||
| Cash Flow From Operations | (9.36 M) | |||
| Earnings Per Share | (1.72) X | |||
| Total Asset | 31.81 M | |||
About Pila Pharma Performance
Assessing Pila Pharma's fundamental ratios provides investors with valuable insights into Pila Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pila Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Pila Pharma AB performance evaluation
Checking the ongoing alerts about Pila Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pila Pharma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pila Pharma AB generated a negative expected return over the last 90 days | |
| Pila Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 719.23 K. Net Loss for the year was (17.21 M) with profit before overhead, payroll, taxes, and interest of 680.94 K. | |
| Pila Pharma generates negative cash flow from operations | |
| About 43.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Pila Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pila Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Pila Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pila Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pila Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pila Pharma's stock. These opinions can provide insight into Pila Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pila Stock Analysis
When running Pila Pharma's price analysis, check to measure Pila Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pila Pharma is operating at the current time. Most of Pila Pharma's value examination focuses on studying past and present price action to predict the probability of Pila Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pila Pharma's price. Additionally, you may evaluate how the addition of Pila Pharma to your portfolios can decrease your overall portfolio volatility.